The integrity of the genome is under constant assault from a variety of endogenous and exogenous sources. Endogenous threats arise from the byproducts of normal cellular metabolism, such as reactive oxygen species (ROS), and from programmed events or errors during DNA replication. Exogenous agents, including environmental toxins, ionizing radiation (IR), and various chemotherapeutic drugs, further challenge the stability of the genetic code. Among the diverse spectrum of DNA lesions that can occur, the DNA double-strand break (DSB) stands out as the most perilous and cytotoxic.
Upon detection of a DSB, the cell must execute a repair strategy. The choice of pathway is highly regulated and largely depends on the cell cycle phase and the nature of the DNA break. Two major pathways predominate in mammalian cells: non-homologous end joining (NHEJ) and homologous recombination (HR).